Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 1;45(6):315-321.
doi: 10.1097/MPH.0000000000002620. Epub 2023 Jan 10.

Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations

Nawal Merjaneh  1 , Hee Kim  1 , Heather Escoto  2 , Jonathan Metts  3 , Anish Ray  4 , Andrew Bukowinski  5 , Zachary LeBlanc  6 , Douglas Fair  7 , Masayo Watanbe  8 , Elizabeth Alva  9 , Kevin Todd  1 , Jessica Daley  5 , Duncan Hartt  7 , Stuart L Cramer  10 , Sara Szabo  1   11 , Joseph G Pressey  1   11
Affiliations

Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations

Nawal Merjaneh et al. J Pediatr Hematol Oncol. .

Abstract

BCOR alterations are described in ultra-rare infantile soft tissue sarcomas including primitive myxoid mesenchymal tumor of infancy and undifferentiated round cell sarcoma (URCS). Previous reports often describe dismal outcomes. Thus, we undertook a retrospective, multi-institutional study of infants with BCOR -rearranged soft tissue sarcomas. Nine patients aged 6 weeks to 15 months were identified. One tumor carried a BCOR :: CCNB3 fusion, whereas 7 tumors harbored internal tandem duplication of BCOR , including 4 cases classified as primitive myxoid mesenchymal tumor of infancy, 1 case as URCS, and 2 cases characterized by a "hybrid morphology" in our evaluation. Four patients underwent upfront surgery with residual disease that progressed locally after a median of 2.5 months. Locoregional recurrences were observed in hybrid patients, and the URCS case recurred with brain metastases. Complete radiographic responses after chemotherapy were achieved in patients treated with vincristine/doxorubicin/cyclophosphamide alternating with ifosfamide/etoposide, vincristine/doxorubicin/cyclophosphamide alternating with cyclophosphamide/etoposide (regimen I), and ifosfamide/carboplatin/etoposide. Seven patients received radiotherapy. With a median of 23.5 months off therapy, 8 patients are with no evidence of disease. In our study, observation was inadequate for the management of untreated postsurgical residual disease. Tumors demonstrated chemosensitivity with anthracycline-based regimens and ifosfamide/carboplatin/etoposide. Radiotherapy was required to achieve durable response in most patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
Radiographic appearance of undifferentiated round cell sarcoma. A, Bright T2 signal mass in the calf with multiple internal septations. B, Postcontrast image demonstrates geographic enhancement.
FIGURE 2.
FIGURE 2.
Radiographic appearance of primitive myxoid mesenchymal tumor of infancy. A, Axial T2 with fat suppression image demonstrates a large lobulated mass in the pelvic cavity. B, The mass extends to the right sciatic notch (arrows).
FIGURE 3.
FIGURE 3.
Primitive myxoid mesenchymal tumor of infancy, classic histomorphology (A, B), hybrid morphology (D, E), and undifferentiated round cell sarcoma morphology (G, H). Immunohistochemical stain for BCOR (C, F).
FIGURE 4.
FIGURE 4.
Swimmer plot survival analysis for the entire cohort. PMMTI indicates primitive myxoid mesenchymal tumor of infancy; URCS, undifferentiated round cell sarcomas.
See this image and copyright information in PMC

References

    1. Sultan I, Casanova M, Al-Jumaily U, et al. Soft tissue sarcomas in the first year of life. Eur J Cancer. 2010;46:2449–2456. - PubMed
    1. Ferrari A, Orbach D, Sultan I, et al. Neonatal soft tissue sarcomas. Semin Fetal Neonatal Med. 2012;17:231–238. - PubMed
    1. Ferrari A, Casanova M, Bisogno G, et al. Rhabdomyosarcoma in infants younger than one year old. Cancer. 2003;97:2597–2604. - PubMed
    1. Orbach D, Sparber-Sauer M, Laetsch TW, et al. Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: international consensus and remaining controversies. Eur J Cancer. 2020;137:183–192. - PubMed
    1. Alaggio R, Ninfo V, Rosolen A, et al. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol. 2006;30:388–394. - PubMed